Published in Stroke on November 01, 2012
Plaque echolucency and stroke risk in asymptomatic carotid stenosis: a systematic review and meta-analysis. Stroke (2014) 1.56
Reliable quantification of BOLD fMRI cerebrovascular reactivity despite poor breath-hold performance. Neuroimage (2013) 0.92
Cerebrovascular reactivity predicts stroke in high-grade carotid artery disease. Neurology (2014) 0.92
"Imaging Evaluation of Collaterals in the Brain: Physiology and Clinical Translation" Curr Radiol Rep (2014) 0.90
PPARγ activation rescues mitochondrial function from inhibition of complex I and loss of PINK1. Exp Neurol (2013) 0.87
Heterogeneous cerebral vasoreactivity dynamics in patients with carotid stenosis. PLoS One (2013) 0.84
Measuring vascular reactivity with breath-holds after stroke: a method to aid interpretation of group-level BOLD signal changes in longitudinal fMRI studies. Hum Brain Mapp (2015) 0.84
Comparison of cerebral blood flow measurement with [15O]-water positron emission tomography and arterial spin labeling magnetic resonance imaging: A systematic review. J Cereb Blood Flow Metab (2016) 0.84
Stroke Caused by Atherosclerosis of the Major Intracranial Arteries. Circ Res (2017) 0.81
Cerebrovascular reserve may be a more accurate predictor of stroke than degree of ICA or MCA stenosis. Med Sci Monit (2014) 0.81
Rapid T2- and susceptometry-based CMRO2 quantification with interleaved TRUST (iTRUST). Neuroimage (2014) 0.81
Compensatory patterns of collateral flow in stroke patients with unilateral and bilateral carotid stenosis. BMC Neurol (2016) 0.80
Carotid artery stenosis: cost-effectiveness of assessment of cerebrovascular reserve to guide treatment of asymptomatic patients. Radiology (2014) 0.79
Quantitative mapping of cerebral metabolic rate of oxygen (CMRO2 ) using quantitative susceptibility mapping (QSM). Magn Reson Med (2014) 0.79
Parametric Cerebrovascular Reserve Images Using Acetazolamide (99m)Tc-HMPAO SPECT: A Feasibility Study of Quantitative Assessment. Nucl Med Mol Imaging (2013) 0.78
Neuroimaging Assessment of Cerebrovascular Reactivity in Concussion: Current Concepts, Methodological Considerations, and Review of the Literature. Front Neurol (2016) 0.78
Cost-Effectiveness of Carotid Plaque MR Imaging as a Stroke Risk Stratification Tool in Asymptomatic Carotid Artery Stenosis. Radiology (2015) 0.78
Acute Preoperative Infarcts and Poor Cerebrovascular Reserve Are Independent Risk Factors for Severe Ischemic Complications following Direct Extracranial-Intracranial Bypass for Moyamoya Disease. AJNR Am J Neuroradiol (2015) 0.77
Time-dependent parameter of perfusion imaging as independent predictor of clinical outcome in symptomatic carotid artery stenosis. BMC Neurol (2016) 0.77
Searching for a truly "iso-metabolic" gas challenge in physiological MRI. J Cereb Blood Flow Metab (2016) 0.76
Multiparametric imaging of brain hemodynamics and function using gas-inhalation MRI. Neuroimage (2016) 0.76
Cerebrovascular reactivity mapping without gas challenges. Neuroimage (2016) 0.75
Simultaneous multi-slice (SMS) acquisition enhances the sensitivity of hemodynamic mapping using gas challenges. NMR Biomed (2016) 0.75
Effect of acupuncture on cerebrovascular reserve in patients with acute cerebral infarction: protocol for a randomized controlled pilot study. Trials (2017) 0.75
Endovascular revascularization of symptomatic chronic middle cerebral artery occlusions: Two case reports. Interv Neuroradiol (2015) 0.75
Cardiometabolic risk factors predict cerebrovascular health in older adults: results from the Brain in Motion study. Physiol Rep (2016) 0.75
Hemodynamic Significance of Internal Carotid or Middle Cerebral Artery Stenosis Detected on Magnetic Resonance Angiography. Yonsei Med J (2015) 0.75
Acetazolamide-augmented dynamic BOLD (aczBOLD) imaging for assessing cerebrovascular reactivity in chronic steno-occlusive disease of the anterior circulation: An initial experience. Neuroimage Clin (2016) 0.75
Assessment of Carotid Artery Stenosis and the Use of Statins. Int J Angiol (2015) 0.75
Comparison of extracranial artery stenosis and cerebral blood flow, assessed by quantitative magnetic resonance, using digital subtraction angiography as the reference standard. Medicine (Baltimore) (2016) 0.75
Evidence for management of carotid artery stenosis. Neurol Med Chir (Tokyo) (2015) 0.75
Opening already occluded middle cerebral artery, internal carotid artery or other cerebral arteries: when, where, how and why? Stroke Vasc Neurol (2017) 0.75
Appropriate management of asymptomatic carotid stenosis. Stroke Vasc Neurol (2016) 0.75
Cerebral blood flow, transit time, and apparent diffusion coefficient in moyamoya disease before and after acetazolamide. Neuroradiology (2016) 0.75
Near-infrared spectroscopy and transcranial sonography to evaluate cerebral autoregulation in middle cerebral artery steno-occlusive disease. J Neurol (2016) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74
Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med (1991) 18.33
Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet (2004) 12.59
Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the Carotid Occlusion Surgery Study randomized trial. JAMA (2011) 4.46
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke (2008) 4.06
Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA (2000) 3.06
Carotid endarterectomy--an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2005) 2.26
Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion. Brain (2001) 1.92
Symptomatic carotid artery occlusion. A reappraisal of hemodynamic factors. Stroke (1997) 1.92
Outcome of carotid artery occlusion is predicted by cerebrovascular reactivity. Stroke (1999) 1.84
Does impaired cerebrovascular reactivity predict stroke risk in asymptomatic carotid stenosis? A prospective substudy of the asymptomatic carotid emboli study. Stroke (2011) 1.73
Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke (2001) 1.71
Course of carotid artery occlusions with impaired cerebrovascular reactivity. Stroke (1992) 1.54
Population-based study of symptomatic internal carotid artery occlusion: incidence and long-term follow-up. Stroke (2004) 1.37
Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid artery occlusive disease. J Vasc Surg (1995) 1.20
Is impaired cerebral vasomotor reactivity a predictive factor of stroke in asymptomatic patients? Stroke (1996) 1.04
Cerebral dysautoregulation and the risk of ischemic events in occlusive carotid artery disease. J Neurol (2008) 1.01
Use of cerebrovascular reactivity in patients with symptomatic major cerebral artery occlusion to predict 5-year outcome: comparison of xenon-133 and iodine-123-IMP single-photon emission computed tomography. J Cereb Blood Flow Metab (2002) 0.90
Clinical implication and prognosis of normal baseline cerebral blood flow with impaired vascular reserve in patients with major cerebral artery occlusive disease. Ann Nucl Med (2010) 0.87
Long-term follow-up of patients with asymptomatic occlusion of the internal carotid artery with good and impaired cerebral vasomotor reactivity. Eur J Neurol (2010) 0.84
Reduced vascular reserve measured by stressed single photon emission computed tomography carries a high risk for stroke in patients with carotid stenosis. Int Angiol (2006) 0.84
Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Clin Oncol (2002) 9.05
DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell (2010) 6.72
Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. J Clin Oncol (2004) 4.68
Perioperative outcomes after unilateral and bilateral total knee arthroplasty. Anesthesiology (2009) 3.66
Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol (2003) 3.56
Perioperative comparative effectiveness of anesthetic technique in orthopedic patients. Anesthesiology (2013) 3.45
Endoscopic pituitary surgery: a systematic review and meta-analysis. J Neurosurg (2009) 2.93
Inpatient falls after total knee arthroplasty: the role of anesthesia type and peripheral nerve blocks. Anesthesiology (2014) 2.73
Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis. Clin Positron Imaging (1999) 2.43
Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA. Hum Gene Ther (2008) 2.42
Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma. J Clin Oncol (2008) 2.40
Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanoma. PLoS One (2012) 2.40
Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol (2002) 2.39
A simple algorithm to predict incident kidney disease. Arch Intern Med (2008) 2.36
Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry (2008) 2.32
Prognostic model for survival in patients with metastatic renal cell carcinoma: results from the international kidney cancer working group. Clin Cancer Res (2011) 2.27
Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg (2008) 2.21
Association between incident cancer and subsequent stroke. Ann Neurol (2015) 2.13
Population-based study of first onset and chronicity in major depressive disorder. Arch Gen Psychiatry (2008) 2.01
Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases. Am J Surg Pathol (2004) 1.97
Rectus flap reconstruction decreases perineal wound complications after pelvic chemoradiation and surgery: a cohort study. Ann Surg Oncol (2005) 1.92
The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol (2005) 1.91
Prognostic factors for survival of patients with stage IV renal cell carcinoma: memorial sloan-kettering cancer center experience. Clin Cancer Res (2004) 1.86
Statin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival. Stroke (2011) 1.84
Beyond repeated-measures analysis of variance: advanced statistical methods for the analysis of longitudinal data in anesthesia research. Reg Anesth Pain Med (2011) 1.84
Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder. J Clin Oncol (2002) 1.82
Variability in response assessment in solid tumors: effect of number of lesions chosen for measurement. Clin Cancer Res (2003) 1.81
Perioperative pulmonary outcomes in patients with sleep apnea after noncardiac surgery. Anesth Analg (2010) 1.80
NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer. Cancer Prev Res (Phila) (2008) 1.71
The impact of sleep apnea on postoperative utilization of resources and adverse outcomes. Anesth Analg (2014) 1.69
Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment. Ann Surg (2008) 1.67
Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma. Leuk Lymphoma (2007) 1.66
Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse. J Clin Oncol (2005) 1.66
Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg (2002) 1.66
The Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART): an adaptive design phase I dose-escalation study of high-dose lovastatin in acute ischemic stroke. Int J Stroke (2008) 1.65
The metabolic syndrome in patients undergoing knee and hip arthroplasty: trends and in-hospital outcomes in the United States. J Arthroplasty (2012) 1.65
Application of the ABCD2 score to identify cerebrovascular causes of dizziness in the emergency department. Stroke (2012) 1.65
Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg (2005) 1.64
Carotid plaque MRI and stroke risk: a systematic review and meta-analysis. Stroke (2013) 1.62
Sleep apnea and total joint arthroplasty under various types of anesthesia: a population-based study of perioperative outcomes. Reg Anesth Pain Med (2013) 1.62
Phase II trial of bortezomib for patients with advanced renal cell carcinoma. J Clin Oncol (2004) 1.58
SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease. Arch Intern Med (2007) 1.56
Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome. Ann Surg Oncol (2004) 1.54
Factors influencing unexpected disposition after orthopedic ambulatory surgery. J Clin Anesth (2012) 1.51
Acute Stroke Imaging Research Roadmap II. Stroke (2013) 1.47
Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factors. Cancer Immun (2007) 1.46
Utilization of critical care services among patients undergoing total hip and knee arthroplasty: epidemiology and risk factors. Anesthesiology (2012) 1.41
Should thrombolysis be given to a stroke patient refusing therapy due to profound anosognosia? Neurology (2004) 1.39
A letter to the editor in reply to "susceptibility to guillain-barre syndrome is associated to polymorphisms of CD1 genes" by Caporale et al. in the J of Neuroimmunology (2006), 177:112-118. J Neuroimmunol (2007) 1.39
Severe ataxia caused by amiodarone. Am J Cardiol (2005) 1.39
Perioperative research fellowship: planning, implementation, experience. Reg Anesth Pain Med (2014) 1.38
Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol (2010) 1.37
Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. J Am Coll Surg (2004) 1.32
Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival. Cancer (2010) 1.31
Strategies for developing biostatistics resources in an academic health center. Acad Med (2013) 1.27
Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis. Ann Surg Oncol (2010) 1.26
Comparative perioperative outcomes associated with neuraxial versus general anesthesia for simultaneous bilateral total knee arthroplasty. Reg Anesth Pain Med (2012) 1.25
Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas. Genes Chromosomes Cancer (2004) 1.24
A rude awakening--the perioperative sleep apnea epidemic. N Engl J Med (2013) 1.24
Multivariate meta-analysis: a robust approach based on the theory of U-statistic. Stat Med (2011) 1.24
Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004). Am J Cardiol (2007) 1.23
Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors. J Clin Oncol (2007) 1.22
Yield of transesophageal echocardiography for nonbacterial thrombotic endocarditis and other cardiac sources of embolism in cancer patients with cerebral ischemia. Am J Cardiol (2006) 1.22
Lenalidomide-induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment-naïve patients undergoing front-line lenalidomide and dexamethasone therapy. Br J Haematol (2007) 1.21
The safety of intravenous thrombolysis for ischemic stroke in patients with pre-existing cerebral aneurysms: a case series and review of the literature. Stroke (2011) 1.17
Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point. J Clin Oncol (2005) 1.16
Detecting pediatric delirium: development of a rapid observational assessment tool. Intensive Care Med (2012) 1.15
Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma. Br J Haematol (2008) 1.14
Changes in the presentation of nodular and superficial spreading melanomas over 35 years. Cancer (2008) 1.14
Testicular seminoma: a clinicopathologic and immunohistochemical study of 105 cases with special reference to seminomas with atypical features. Int J Surg Pathol (2002) 1.12
Clinical relevance of neutral endopeptidase (NEP/CD10) in melanoma. J Transl Med (2007) 1.12
Mortality of patients with respiratory insufficiency and adult respiratory distress syndrome after surgery: the obesity paradox. J Intensive Care Med (2011) 1.12
Perioperative mortality in patients with pulmonary hypertension undergoing major joint replacement. Anesth Analg (2010) 1.10
Inappropriate medication in a national sample of US elderly patients receiving home health care. J Gen Intern Med (2012) 1.10
High-dose lovastatin for acute ischemic stroke: results of the phase I dose escalation neuroprotection with statin therapy for acute recovery trial (NeuSTART). Cerebrovasc Dis (2009) 1.10
Developing patient-centered outcome measures for evaluating vasospasm in aneurysmal subarachnoid hemorrhage. Acad Radiol (2009) 1.07
CT angiography with whole brain perfused blood volume imaging: added clinical value in the assessment of acute stroke. Stroke (2002) 1.05
Bilateral total knee arthroplasty: risk factors for major morbidity and mortality. Anesth Analg (2011) 1.04
Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia. Cancer (2008) 1.04
Meta-analysis of sentinel lymph node positivity in thin melanoma (<or=1 mm). Cancer (2009) 1.03
Arterial input function placement for accurate CT perfusion map construction in acute stroke. AJR Am J Roentgenol (2010) 1.02
Total hip and total knee arthroplasties: trends and disparities revisited. Am J Orthop (Belle Mead NJ) (2010) 1.01
Cicada wings: a stamp from nature for nanoimprint lithography. Small (2006) 1.01
Comparison of CT perfusion and digital subtraction angiography in the evaluation of delayed cerebral ischemia. Acad Radiol (2011) 0.99
Imaging recommendations for acute stroke and transient ischemic attack patients: a joint statement by the American Society of Neuroradiology, the American College of Radiology and the Society of NeuroInterventional Surgery. J Am Coll Radiol (2013) 0.99
Cardiogenic and aortogenic brain embolism. J Am Coll Cardiol (2008) 0.99
Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis. Ann Surg Oncol (2011) 0.97
Blindness and necrotizing fasciitis after liposuction and fat transfer. Plast Reconstr Surg (2010) 0.97
Transient aphasia and reversible major depression due to a giant sagittal sinus dural AV fistula. Neurology (2003) 0.97
Validation of a new reference standard for the diagnosis of vasospasm. Acad Radiol (2010) 0.96
Recent chemotherapy reduces the sensitivity of [18F]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases. J Clin Oncol (2005) 0.95